Vaginimicrobium propionicum

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Vaginimicrobium propionicum is a Gram-positive, non-spore-forming, microaerophilic, non-motile, pleiomorph rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 50.6%. Vaginimicrobium propionicum is likely to be transient and not a long-term gut coloniser. (Diop2020)



  • This organism has been recovered from a healthy vagina, France. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.
    • GENERAL CHARACTERISTICS (Diop2020);
    Character Response
  • 🧂
  • Salt tolerance:
  • tolerates 0.5% salt;
  • pH
  • Acidity tolerance:
  • Grows optimally at pH 6-7.5.
  • 🌡
  • Temperature tolerance:
  • grows at 28℃; grows at 42℃; Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • L-arabinose; glucose; xylose; maltose; melezitose; sucrose; trehalose; salicin;
  • Active enzymes:
  • Arg arylamidase; α-glucosidase; β-glucosidase; β-glucuronidase; Leu arylamidase; Phe arylamidase; Pro arylamidase; Tyr arylamidase; urease; naphthol-ASBI-P;
    • SPECIAL FEATURES (Diop2020);
    Character Response
  • ✓
  • Metabolites produced:
  • acetate; propionate; isobutyrate;
  • ✗
  • Metabolites not produced:
  • indole;
  • ✗
  • NO3➔NO2:
  • not reduced
    • RESPONSE TO ANTIBIOTICS (Diop2020);
    Class Active Resistant
  • Penicillins:
  • amoxicillin; benzylpenicillin; imipenem;
  • Vancomycins:
  • vancomycin;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Actinobacteria Class:  Actinomycetia Order:  Propionibacteriales Family:  Propionibacteriaceae Genus:  Vaginimicrobium Gram stain:  + O2 Relation.:  microaerophilic Spore:  No spore Motility:  Sessile Morphology:  Pleiomorph rod
    Health:  Unknown
    Source:  a healthy vagina, France
    DNA G+C(%):  50.6
    Opt. T:  37℃
    Lower T(℃):  28(+)
    High T(℃):  42(+)
    NaCl 0.5-2%:  0.5(+)
    Opt. pH:  6-7.5
    		Aesculin:  neg Gelatin:  neg
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    L-Arabinose:  + Glucose:  + Mannose:  neg Xylose:  + Cellubiose:  neg Lactose:  neg Maltose:  + Melezitose:  + Sucrose:  + Trehalose:  + Glycerol:  neg Mannitol:  neg Sorbitol:  neg Salicin:  +
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg Urease:  + α-Arab:  neg Ac-β-glcamnd:  neg α-Fucosidase:  neg α-Galactosidase:  neg β-Galactosidase:  neg α-Glucosidase:  + β-Glucosidase:  + β-Glucuronidase:  + α-Mannosidase:  neg Chymotrypsin:  neg Trypsin:  neg AlanineAA:  neg ArgAA:  + CystineAA:  neg GlyAA:  neg HisAA:  neg LeuAA:  + LeuGlyAA:  neg ProAA:  + PheAA:  + PyrogluAA:  neg SerAA:  neg TyrAA:  + ValAA:  w AlkalineP:  neg AcidP:  neg Esterase(C4):  w EstLip(C8):  neg Lipase(C14):  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		Acetate:  + Propionate:  + Isobutyrate:  + Indole:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  Sens
    benzyl-pen:  Sens
    imipenem:  Sens
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    vancomycin:  Sens

    References

    SPECIFIC REFERENCES FOR VAGINIMICROBIUM PROPIONICUM
  • Diop2020 - Vaginimicrobium propionicum gen. nov., sp. nov., a novel propionic acid bacterium derived from human vaginal discharge.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR VAGINIMICROBIUM PROPIONICUM
  • New2022 - Collective effects of human genomic variation on microbiome function.
  • ...............................
    • Added: March 18, 2022